Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Genetic testing for pheochromocytoma Karasek D; Frysak Z; Pacak KCurr Hypertens Rep 2010[Dec]; 12 (6): 456-64Pheochromocytomas (PHEOs) and paragangliomas (PGLs) are rare, catecholamine-producing tumors that are usually sporadic. However, about 30% of these tumors have been identified as being of inherited origin. To date, nine genes have been confirmed as participating in PHEO or PGL tumorigenesis. Germline mutations were found in 100% of syndromic cases and in about 90% of patients with positive familial history. In nonsyndromic patients with apparently sporadic tumors, genetic mutations have been found in up to 27%, and genetic testing is now recommended for all patients with PHEOs and PGLs. Patients with syndromic lesions, a positive family history, or both should be tested for the appertaining gene. Recent discoveries have shown that the order of tested genes in nonsyndromic, nonfamilial cases can be based on histologic evaluation, location, and the biochemical phenotype of PHEOs and PGLs--the "rule of three." Identification of a gene mutation may lead to early diagnosis and treatment, regular surveillance, and a better prognosis for patients and their relatives.|*Adrenal Gland Neoplasms/diagnosis/genetics/mortality/therapy[MESH]|*Genetic Testing[MESH]|*Multiple Endocrine Neoplasia Type 2a/diagnosis/genetics/mortality/therapy[MESH]|*Pheochromocytoma/diagnosis/genetics/mortality/therapy[MESH]|Adult[MESH]|Asymptomatic Diseases/mortality[MESH]|Catecholamines/genetics[MESH]|Early Detection of Cancer[MESH]|Germ-Line Mutation[MESH]|Humans[MESH]|Middle Aged[MESH]|Succinate Dehydrogenase/genetics[MESH]|Survival Rate[MESH]|Treatment Outcome[MESH] |
